Showing results (981-990 of 2,180) with videos related to
Sort By:
Pageof 218
Journal of Biopharmaceutical Statistics|March 3, 2023
Weighted log-rank tests for censored data under Wei's urn design: saddlepoint approximation and confidence intervalsAbd El-Raheem M Abd El-Raheem, Ehab F Abd-ElfattahJournal of Biopharmaceutical Statistics|March 6, 2023
Practical guidance on modeling choices for the virtual twins methodChuyu Deng, Jack M Wolf, David M Vock, et al.Journal of Biopharmaceutical Statistics|March 7, 2023
Dose-finding based on feasibility and late-onset toxicity in adoptive cell therapy trialsEvan M Bagley, Nolan A WagesJournal of Biopharmaceutical Statistics|November 7, 2022
Evidence synthesis analysis with prioritized benefit outcomes in oncology clinical trialsYing Cui, Gaohong Dong, Pei Fen Kuan, et al.Journal of Biopharmaceutical Statistics|August 24, 2022
PMED: Optimal Bayesian Platform Trial Design with Multiple EndpointsTian He, Rachael Liu, Meizi Liu, et al.Journal of Biopharmaceutical Statistics|August 30, 2021
Study design for a three-arm equivalence clinical trial with binomially distributed outcomesYi-Kuan Tseng, Ken-Ning HsuJournal of Biopharmaceutical Statistics|March 6, 2023
Estimation of the selected treatment mean in two stage drop-the-losers designMasihuddin, Neeraj MisraJournal of Biopharmaceutical Statistics|February 2, 2023
A promising subgroup identification method based on a genetic algorithm for censored survival dataLiang Zhao, Wenjie Zhang, Ying Wu, et al.Journal of Biopharmaceutical Statistics|February 18, 2026
Win statistics (win ratio, win odds, and net benefit): Noncollapsibility and standardization for randomized clinical trialsGaohong Dong, Margaret Gamalo-Siebers, Ying Cui, et al.Journal of Biopharmaceutical Statistics|February 10, 2026
Application of principal stratification in crossover and parallel clinical trial designsBahareh Afhami, Mohsen Madadi, Mohsen Rezapour, et al.Pageof 218